Patent 7123957 was granted and assigned to TransPharma Medical on October, 2006 by the United States Patent and Trademark Office.
A device for ablating the stratum corneum epidermidis of a subject, including a plurality of electrodes, which are applied to the subject's skin at respective points. A power source applies electrical energy between two or more of the plurality of electrodes, in order to cause ablation of the stratum corneum primarily in an area intermediate the respective points.